Related Experiment Video
Updated: Dec 6, 2025

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
Published on: November 19, 2019
Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer
Stephan B Dreyer1, Rosie Upstill-Goddard2, Viola Paulus-Hock3
1Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom.
Background & Aims:
Continuing recalcitrance to therapy cements pancreatic cancer (PC) as the most lethal malignancy, which is set to become the second leading cause of cancer death in our society. The study aim was to investigate the association between DNA damage response (DDR), replication stress, and novel therapeutic response in PC to develop a biomarker-driven therapeutic strategy targeting DDR and replication stress in PC.
Methods:
We interrogated the transcriptome, genome, proteome, and functional characteristics of 61 novel PC patient-derived cell lines to define novel therapeutic strategies targeting DDR and replication stress. Validation was done in patient-derived xenografts and human PC organoids.
Results:
Patient-derived cell lines faithfully recapitulate the epithelial component of pancreatic tumors, including previously described molecular subtypes. Biomarkers of DDR deficiency, including a novel signature of homologous recombination deficiency, cosegregates with response to platinum (P < .001) and PARP inhibitor therapy (P < .001) in vitro and in vivo. We generated a novel signature of replication stress that predicts response to ATR (P < .018) and WEE1 inhibitor (P < .029) treatment in both cell lines and human PC organoids. Replication stress was enriched in the squamous subtype of PC (P < .001) but was not associated with DDR deficiency.
Conclusions:
Replication stress and DDR deficiency are independent of each other, creating opportunities for therapy in DDR-proficient PC and after platinum therapy.
Insights
Pancreatic cancer (PC) therapies are challenging. This study identifies biomarkers for DNA damage response (DDR) deficiency and replication stress, guiding new targeted treatments for PC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Pancreatic cancer (PC) remains a highly lethal malignancy with limited therapeutic options.
- Developing novel, biomarker-driven strategies is crucial for improving PC treatment outcomes.
Purpose of the Study:
- To investigate the association between DNA damage response (DDR), replication stress, and therapeutic response in PC.
- To establish a biomarker-driven strategy targeting DDR and replication stress for PC treatment.
Main Methods:
- Interrogation of transcriptome, genome, proteome, and functional characteristics of 61 PC patient-derived cell lines.
- Validation in patient-derived xenografts and human PC organoids.
- Development of novel signatures for DDR deficiency and replication stress.
Main Results:
- Biomarkers for DDR deficiency, including homologous recombination deficiency, correlate with response to platinum and PARP inhibitor therapies.
- A novel replication stress signature predicts response to ATR and WEE1 inhibitor treatments.
- Replication stress is prevalent in the squamous subtype of PC and independent of DDR deficiency.
Conclusions:
- DDR deficiency and replication stress are distinct pathways in PC, offering therapeutic opportunities.
- Targeting DDR and replication stress provides a promising avenue for novel PC therapies, even in DDR-proficient tumors or post-platinum treatment.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The DNA Replication Fork
Overview of DNA Repair
Chemically...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

